Genta, Inc (fka GNTAQ)

[tothe]

Holder, the large shareholder longs may also be in a buying strategy to keep the R/S under 1-100. So do not write off their buying here completely. They are the seasoned bio-tech & drug investors who have a deep knowledge of the industry. They just may be playing their cards right in this case, we just may be the one's who are wrong on the long term and even half right on intermediate term. Ya, never know...you might fall in love with this stock too.